Trevena Inc (TRVN)
0.4126
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.4295
+0.02
(+4.10%)
After-Hours: 20:00
Trevena Cash from Investing (Quarterly): -0.021M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.021M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | -0.02M |
| March 31, 2023 | |
| December 31, 2022 | 18.00M |
| September 30, 2022 | 11.99M |
| June 30, 2022 | -29.98M |
| March 31, 2022 | |
| December 31, 2021 | 1.164M |
| September 30, 2021 | -1.18M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | |
| December 31, 2020 | -0.027M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 3.50M |
| December 31, 2019 | 12.00M |
| September 30, 2019 | 14.77M |
| June 30, 2019 | 9.857M |
| March 31, 2019 | -11.04M |
| December 31, 2018 | 17.42M |
| September 30, 2018 | -6.406M |
| Date | Value |
|---|---|
| June 30, 2018 | 4.027M |
| March 31, 2018 | 5.954M |
| December 31, 2017 | 8.778M |
| September 30, 2017 | 10.22M |
| June 30, 2017 | 7.044M |
| March 31, 2017 | 6.734M |
| December 31, 2016 | 7.406M |
| September 30, 2016 | 12.98M |
| June 30, 2016 | 20.92M |
| March 31, 2016 | -3.509M |
| December 31, 2015 | 3.20M |
| September 30, 2015 | -67.44M |
| June 30, 2015 | 8.516M |
| March 31, 2015 | -1.214M |
| December 31, 2014 | -70.74M |
| September 30, 2014 | -0.2302M |
| June 30, 2014 | -0.1707M |
| March 31, 2014 | -0.0206M |
| December 31, 2013 | -0.0618M |
| September 30, 2013 | -0.0328M |
| June 30, 2013 | -0.039M |
| March 31, 2013 | -0.0064M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-29.98M
Minimum
Jun 2022
18.00M
Maximum
Dec 2022
2.504M
Average
--
Median
Jun 2020
Cash from Investing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 9.462M |
| iBio Inc | 0.00 |
| Theriva Biologics Inc | -0.056M |
| Oragenics Inc | -1.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.985M |
| Cash from Financing (Quarterly) | 4.029M |
| Free Cash Flow | -33.08M |
| Free Cash Flow Per Share (Quarterly) | -0.3812 |
| Free Cash Flow to Equity (Quarterly) | -7.173M |
| Free Cash Flow to Firm (Quarterly) | -4.547M |
| Free Cash Flow Yield | -630.1% |